Cargando…
Research progress on amyopathic dermatomyositis associated with interstitial lung disease
Autores principales: | Bai, Yu, Tao, Xiao-Nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028195/ https://www.ncbi.nlm.nih.gov/pubmed/31923118 http://dx.doi.org/10.1097/CM9.0000000000000574 |
Ejemplares similares
-
Risk factors of interstitial lung diseases in clinically amyopathic dermatomyositis
por: Gan, Yu-Zhou, et al.
Publicado: (2020) -
Fatal rapidly progressive interstitial lung disease in a patient with amyopathic dermatomyositis
por: Mobeireek, Abdullah, et al.
Publicado: (2021) -
Pirfenidone in patients with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis
por: Li, Ting, et al.
Publicado: (2016) -
Anti-MDA5 Associated Clinically Amyopathic Dermatomyositis With Rapidly Progressive Interstitial Lung Disease
por: Tavakolian, Kameron, et al.
Publicado: (2022) -
Cytokine profiles of amyopathic dermatomyositis with interstitial lung diseases treated with mycophenolate
por: Hayashi, Masachika, et al.
Publicado: (2017)